ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BGO Bango Plc

133.50
0.00 (0.00%)
13 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bango Plc LSE:BGO London Ordinary Share GB00B0BRN552 ORD 20P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 133.50 130.00 137.00 133.50 133.50 133.50 50,667 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Radiotelephone Communication 46.1M -8.83M -0.1150 -11.61 102.49M
Bango Plc is listed in the Radiotelephone Communication sector of the London Stock Exchange with ticker BGO. The last closing price for Bango was 133.50p. Over the last year, Bango shares have traded in a share price range of 95.60p to 210.00p.

Bango currently has 76,774,700 shares in issue. The market capitalisation of Bango is £102.49 million. Bango has a price to earnings ratio (PE ratio) of -11.61.

Bango Share Discussion Threads

Showing 11126 to 11150 of 11425 messages
Chat Pages: 457  456  455  454  453  452  451  450  449  448  447  446  Older
DateSubjectAuthorDiscuss
08/4/2024
09:20
Great Hastings, look forward to it thanks
amt
08/4/2024
09:18
Nice catch up a little while ago and I'll try and get a write up out for interest tomorrow. Suffice to say, no raise planned and reiterated as stressed by Anil to me in January and they are comfortable and confident on that front moving forward.
hastings
08/4/2024
09:08
That's where the money in the bank went on paying down debt I'm all for that at the current interest rates
tnt99
08/4/2024
08:55
Yep Frontier is a great example - ironically on the same business park as Bango. And even more ironically that I increased my Bango position at the detriment of Frontier!
jasperlachat
08/4/2024
08:54
I exchanged a few emails with Paul Larbey after the Jan fiasco and I asked about the 2024 forecasts specifically as they look to me like Q4 2023 * 4. His view was that after the forecast miss in 2023 they wanted to focus on setting a reasonable bar for 2024 and then being able to guide higher later in 2024. I don't think he wants to miss on expectations again, ever ? I would expect a statement at next trading update guiding to being above market expectations
adtraderuae
08/4/2024
08:47
Yes technical traders will arrive once the trading range has been broken imo. Same thing happened at FDEV recently. That closed above 162 last week confirming the breakout. Now look at the price.
parob
08/4/2024
08:45
Leaves plenty of room for upgrades.
parob
08/4/2024
08:45
What does that mean about technical traders, will that push the price higher ?
amt
08/4/2024
08:42
About to break the trading range we've been stuck in. Now watch the technical traders arrive over the coming days once it's confirmed.
parob
08/4/2024
08:29
Agree, got to be upside potential on those numbers. Speaking with shortly, so hopefully get a better feel!
hastings
08/4/2024
08:28
The forecasts seem so conservative, don’t get it.
jasperlachat
08/4/2024
08:26
Thanks, glad I loaded up before. Its impossible to buy. I am in danger of getting back into profit at this rate
amt
08/4/2024
08:23
Singer taster - without sub from Research Tree

A new Bango: 77% ARR growth and 137% NRR

With the majority of the Docomo integration now complete and a record Digital Vending Machine (‘DVM’) pipeline (that is converting, with a 20%+ yoy increase in Q1’24 revenues), we believe a new Bango is emerging with a highly cash generative DCB business and a fast growing, newly reported DVM revenue line that should support high incremental revenue growth. While the January 2024 trading update was disappointing, if we look at Bango’s H2’23 vs H2’22 performance, total revenues increased 46% yoy with a c.56% incremental revenue margin (i.e. drop through to EBITDA). We leave our forecasts unchanged which assumes a more than doubling of adj EBITDA yoy, this is supported by the Q1’24 performance and high operational gearing within the business (e.g. H2’23 performance). We reiterate our Buy and 220p TP.

missmimz
08/4/2024
08:14
No, but the market likes the report.
The administration costs increasing by 14m is where the issue with missing targets lies. They need to get back to the same admin costs as before. That would save 14m per year.

amt
08/4/2024
08:11
Anyone seen the note from Singer?
dr biotech
08/4/2024
08:07
I don't see any reason why they can't cut admin costs by 6m and GP should increase by 7m so that's 13m better in 2024 without potentially much more from DVM
amt
08/4/2024
07:59
No hidden surprises, strong first quarter, guidance for the full year reiterated. The seller should have been shaken out during the last three months of consolidation in a tight trading range. Need to break out of this range now. A close above 117p should do it over the coming days, then the recovery should gather pace imo.
parob
08/4/2024
07:55
They (especially Raymondo) have gone into detail which was missing from the TU in January which I expect will be received positively, that said if the recent seller still has stock to unload then we may not see any recovery in the share price until he’s out, Q1 sounds positive
lentjes
08/4/2024
07:55
I still think that Boku could step in to double their EUS and get the DVM plus audiences software.
amt
08/4/2024
07:40
Results confirm no more unwanted surprises.
The opportunity for DVM is enormous and that is where the future is.
Audiences to be used in DVM but joint venture wound down.
The worst is over so should expect a steady recovery in the year ahead.
I think the Financials should have had more to say about the impact of Fx in numbers rather than comments. Plus the inter Co loans issue is unclear, now in reserves whereas they previously mentioned it hitting p&l.

amt
08/4/2024
07:35
Some pretty strong statements from Chair, CEO and CFO should I think reassure the market. Looking forward to watching the body language at the 10am presentation.
18bt
08/4/2024
07:35
Web links:

RNS
hxxps://polaris.brighterir.com/public/bango_plc/news/rns/story/w1k0eex

Annual Report
hxxps://bangoinvestor.com/wp-content/uploads/2024/04/Annual-report-FY23-Interactive.pdf

weblinkman
08/4/2024
07:29
No further docomo surprises…
dr biotech
08/4/2024
07:23
no comments after 15 min... wow

it sounds very good to me on the surface - growth. to be able to see the reality beneath - costs, cash situation ... i will have to read it all

outlook did not given me the answers in an easy way ....
tech companies always give numbers of growth in contracts

but rarely net cash/ebitda etc

which is of the same importance

kaos3
08/4/2024
07:19
Wow, those accounts are awful, balance sheet looks incredibly weak. This looks uninvestible at first glance but will post some more detailed analysis later on.
74tom
Chat Pages: 457  456  455  454  453  452  451  450  449  448  447  446  Older

Your Recent History

Delayed Upgrade Clock